相关实验视频
Updated: Jul 25, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.2K
针对妇科恶性瘤的免疫疗法的进展
1Women's Reproductive Health Laboratory of Zhejiang Province, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China.
Critical reviews in oncology/hematology
|June 29, 2023
概括
免疫疗法对妇科癌症有希望,比传统治疗方法提供更好的抗瘤活性. 需要进一步的研究和临床试验才能充分发挥其在治疗晚期或耐药癌症方面的潜力.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症免疫疗法癌症免疫疗法
- 翻译医学是一种翻译医学.
背景情况:
- 目前对妇科恶性瘤的治疗方法 (手术,化疗,放射治疗) 有局限性,特别是在晚期或耐药的癌症中.
- 复杂的病例,如晚期子宫癌和子宫内膜癌 (EC),耐化疗的孕期热囊细胞瘤和抗白金的卵巢癌,构成了重大挑战.
- 免疫疗法是一个有前途的替代方案,有可能改善抗瘤活性并降低毒性.
研究的目的:
- 审查当前的情况和近期的免疫疗法在妇科恶性瘤的进展.
- 讨论阻碍妇科癌症免疫治疗临床应用的挑战.
- 探索免疫治疗治疗这些癌症的未来方向.
主要方法:
- 关于临床前研究和临床试验的综合文献综述.
- 在妇科癌症背景下分析免疫治疗的疗效和安全性.
- 讨论现有挑战和未来的研究需求.
主要成果:
- 免疫疗法显示出在患有妇科恶性瘤的患者中改善预后的潜力.
- 与传统疗法相比,它提供了更好的抗瘤效果.
- 虽然有希望,免疫疗法的发展落后于临床需求,需要进一步调查.
结论:
- 免疫疗法是治疗妇科恶性瘤,特别是晚期或耐药类型的发展和可行的替代方案.
- 正在取得重大进展,但更广泛的临床前研究和大规模的临床试验至关重要.
- 应对当前的挑战将为更广泛的临床采用和改善患者治疗结果铺平道路.
更多相关视频
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.5K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
相关概念视频
Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
Cancer Vaccines
428
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
428
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K